Glynn Capital Management LLC Raises Position in Oscar Health, Inc. (NYSE:OSCR)

Glynn Capital Management LLC grew its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 14.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,115,217 shares of the company's stock after acquiring an additional 381,980 shares during the period. Oscar Health accounts for approximately 10.7% of Glynn Capital Management LLC's investment portfolio, making the stock its biggest holding. Glynn Capital Management LLC owned approximately 1.24% of Oscar Health worth $40,840,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Southeastern Asset Management Inc. TN grew its stake in shares of Oscar Health by 52.2% in the 4th quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company's stock valued at $42,082,000 after buying an additional 1,073,359 shares during the period. Jacobs Levy Equity Management Inc. grew its stake in shares of Oscar Health by 37.8% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 1,741,306 shares of the company's stock valued at $23,403,000 after buying an additional 477,634 shares during the period. Man Group plc grew its stake in shares of Oscar Health by 344.8% in the 4th quarter. Man Group plc now owns 1,813,216 shares of the company's stock valued at $24,370,000 after buying an additional 1,405,554 shares during the period. Toronto Dominion Bank acquired a new stake in shares of Oscar Health in the 4th quarter valued at about $1,008,000. Finally, Concurrent Investment Advisors LLC acquired a new stake in shares of Oscar Health in the 1st quarter valued at about $677,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Stock Performance

Shares of NYSE:OSCR traded up $0.25 during mid-day trading on Friday, reaching $14.45. The company had a trading volume of 27,810,569 shares, compared to its average volume of 39,649,032. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.22. The firm has a market cap of $3.68 billion, a price-to-earnings ratio of 51.59 and a beta of 1.90. The company's 50-day moving average price is $15.99 and its 200-day moving average price is $14.92. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. The company had revenue of $3 billion for the quarter, compared to analysts' expectations of $2.87 billion. Oscar Health had a net margin of 1.22% and a return on equity of 10.59%. Oscar Health's revenue was up 42.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.62 EPS. As a group, equities research analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Insider Activity at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the sale, the director owned 64,512 shares of the company's stock, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 24.39% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on OSCR shares. Wells Fargo & Company downgraded Oscar Health from an "equal weight" rating to an "underweight" rating and reduced their target price for the company from $16.00 to $10.00 in a research note on Friday, July 11th. Raymond James Financial downgraded Oscar Health from an "outperform" rating to a "market perform" rating in a research note on Tuesday, June 24th. Wall Street Zen downgraded Oscar Health from a "buy" rating to a "hold" rating in a research note on Sunday, June 8th. Piper Sandler downgraded Oscar Health from an "overweight" rating to a "neutral" rating and set a $14.00 price target for the company. in a research note on Monday, July 14th. Finally, Baird R W downgraded Oscar Health from a "strong-buy" rating to a "hold" rating in a research note on Friday. Five research analysts have rated the stock with a sell rating and five have given a hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $12.21.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.